Tressa D. Randall

Senior Director, Regulatory Affairs

Tressa D. Randall joined VentiRx in 2007 as Senior Director of Regulatory Affairs, bringing with her 20 years of experience in drug development. Prior to VentiRx, Ms. Randall worked at ICOS Corporation as Principal Regulatory Scientist, and earlier as Senior Manager, Regulatory Affairs, with primary responsibility for numerous INDs and international submissions of treatments for infectious, inflammatory and urological conditions. During her 10 years with ICOS, she played a key role in the strategic development of the Phase 3 programs for severe sepsis and ischemic stroke indications. Most recently, Ms. Randall was a significant contributor to supplemental NDA application activities for a new dosing regimen for Cialis®, a treatment for erectile dysfunction.

Prior to her work at ICOS, Ms. Randall spent 10 years at NeoRx Corporation in both regulatory and clinical analytical research capacities. Her contributions to the oncology programs supported the approval of a diagnostic cancer imaging agent and facilitated numerous IND submissions for other oncology therapeutic drug development programs at NeoRx.

Ms. Randall holds a B.S. in Microbiology from Washington State University.